A Prospective, Observational, Multi-country, Post-marketing Study on the Safety and Efficacy of Voraxaze (Glucarpidase) in Subjects with Delayed Methotrexate Elimination or at Risk of Methotrexate Toxicity

Title

Code

PR001-CNL-pro103

Type

Osservazionale

Start Year

2026

Status

In Corso

Principal Investigator

051-6365515

marilena.cesari@ior.it

Cesari Marilena, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PR001-CNL-pro103

Thursday 16 April 2026, 16:41

PG0002949_2026_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

A Prospective, Observational, Multi-country, Post-marketing Study on the Safety and Efficacy of Voraxaze (Glucarpidase) in Subjects with Delayed Methotrexate Elimination or at Risk of Methotrexate Toxicity

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

A Prospective, Observational, Multi-country, Post-marketing Study on the Safety and Efficacy of Voraxaze (Glucarpidase) in Subjects with Delayed Methotrexate Elimination or at Risk of Methotrexate Toxicity

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in